NCCAM Exec Says CAM Dosing Studies Needed Before Clinical Trials
This article was originally published in The Tan Sheet
Executive Summary
The National Center for Complimentary & Alternative Medicine at NIH should conduct more preclinical research before investing in Phase II clinical trials, NCCAM Deputy Director Margaret Chesney, PhD, recommends
You may also be interested in...
Echinacea Ineffective For Cold Prevention, Treatment – NEJM Study
Neither preemptive nor early treatment with echinacea prevents the common cold or reduces the severity of its symptoms, a study published in the July 28 New England Journal of Medicine states
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement